News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Pivotal bioVenture Partners Fund I, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 119,048 shares
@ $4.8, valued at
$571.4k
Bought 714,285 shares
@ $4.8, valued at
$3.4M
|
|
| 04/20/2022 |
4
| Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,070,000 shares
@ $3.69, valued at
$3.9M
|
|
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Pivotal bioVenture Partners Fund I, L.P. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Converted 359,267 shares
@ $0
Converted 458,425 shares
@ $0
Bought 337,724 shares
@ $15, valued at
$5.1M
Converted 7,446,904 options to buy
@ $0
Converted 9,502,249 options to buy
@ $0 |
|
|
|